Gene Therapy Market Size, Share, And Growth Report 2032

Gene Therapy Market: Size

The global Gene Therapy Market size was worth around USD 8.86 billion in 2023 and is predicted to grow to around USD 41.40 billion by 2032 with a compound annual growth rate (CAGR) of roughly 18.68% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Gene Therapy Market on a global and regional level.

Request Free Sample

Gene Therapy Market: Overview

Gene therapy is the process where a DNA is inserted into a patient to treat a specific disease. The DNA is carefully selected to correct the effect of a mutated gene. Gene therapy is suitable for treating cancer by destroying a certain group of cells. Gene therapy has the potential to eventually eliminate genetic defects, kill cancerous cells, and prevent cardiovascular diseases. A fundamental requirement for gene therapy is the correct identification of genes coding for diseases.

As per the World Health Organization, there were 14 million new cancer cases in 2012 and 8.8 million cancer-related deaths in 2015 globally. The increasing prevalence of genetic disorders in newborns and life-threatening diseases, such as cardiovascular diseases and cancer, across the globe is expected to be the major driver of the global gene therapy market in the upcoming years. In addition, the growing need for targeted treatment and increasing awareness and acceptance of personalized medicines among patients are likely to further trigger the global gene therapy industry in the future. However, the requirement of an individual case-by-case approach and high treatment cost might hamper the gene therapy market on a global scale in the estimated timeframe.

Request Free Sample

Gene Therapy Market: Segmentation

The study provides a decisive view of the gene therapy market by segmenting the market based on type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on the type, the gene therapy market is bifurcated into somatic cell gene therapy and germ cell gene therapy. The somatic cell segment holds the maximum share of the global gene therapy market.

Based on application, the gene therapy market is classified into genetic disorders, cancer, cardiovascular diseases, and others. Genetic disorders are likely to hold a significant market share over the forecast time period.

Gene Therapy Market: Report Scope

Gene Therapy Market: Regional Analysis

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

By region, North America dominated the global gene therapy in 2023 market and is expected to remain the dominant region over the forecast time period as well. This can be attributed to the developed healthcare infrastructure, favorable government policies, and research activities across the region. The Asia Pacific is likely to register the fastest rate of growth in the gene therapy market in the upcoming years, owing to the low cost of clinical trials and large regional population, especially in India, China, and Japan. The Latin American gene therapy market is projected to grow moderately over the estimated time period. The Middle Eastern and African market is projected to experience noticeable growth in the years ahead.

Gene Therapy Market: Competitive Players

Some key players of the gene therapy market include:

• UniQure N.V
• Spark Therapeutics LLC
• Bluebird Bio
• Juno Therapeutics
• GlaxoSmithKline
• Celgene Corporation
• Shire Plc
• Sangamo Biosciences
• Dimension Therapeutics
• Voyager Therapeutics
• Human Stem Cell Institute
• Bristol Myer’s Squibb
• Chiesi Farmaceutici S.p.A.

The Global Gene Therapy Market is segmented as follows:

Global Gene Therapy Market: By Type

• Somatic Cell Gene Therapy
• Germ Cell Gene Therapy

Global Gene Therapy Market: By Application

• Genetic Disorders
• Cancer
• Cardiovascular Disease
• Others

Global Gene Therapy Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa